Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 12/2014

Open Access 01-12-2014 | Original Paper

Cognitive and Field Testing of a New Set of Medication Adherence Self-Report Items for HIV Care

Authors: Ira B. Wilson, Floyd J. Fowler Jr., Carol A. Cosenza, Joanne Michaud, Judy Bentkover, Aadia Rana, Laura Kogelman, William H. Rogers

Published in: AIDS and Behavior | Issue 12/2014

Login to get access

Abstract

We conducted four rounds of cognitive testing of self-report items that included 66 sociodemographically diverse participants, then field tested the three best items from the cognitive testing in a clinic waiting room (N = 351) and in an online social networking site for men who have sex with men (N = 6,485). As part of the online survey we conducted a randomized assessment of two versions of the adherence questionnaire—one which asked about adherence to a specific antiretroviral medication, and a second which asked about adherence to their “HIV medicines” as a group. Participants were better able to respond using adjectival and adverbial scales than visual analogue or percent items. The internal consistency reliability of the three item adherence scale was 0.89. Mean scores for the two different versions of the online survey were similar (91.0 vs. 90.2, p < 0.05), suggesting that it is not necessary, in general, to ask about individual medications in an antiretroviral therapy regimen when attempting to describe overall adherence.
Appendix
Available only for authorised users
Literature
1.
Haubrich RH, Little SJ, Currier JS, Forthal DN, Kemper CA, Beall GN, et al. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. AIDS. 1999;13:1099–107.PubMedCrossRef
2.
Paterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30.PubMedCrossRef
3.
Bangsberg DR, Hecht FM, Clague H, Charlebois ED, Ciccarone D, Chesney M, et al. Provider assessment of adherence to HIV antiretroviral therapy. J Acquir Immune Defic Syndr. 2001;26(5):435–42.PubMedCrossRef
4.
Gross R, Bilker WB, Friedman HM, Coyne JC, Strom BL. Provider inaccuracy in assessing adherence and outcomes with newly initiated antiretroviral therapy. AIDS. 2002;16(13):1835–7.PubMedCrossRef
5.
Wendel CS, Mohler MJ, Kroesen K, Ampel NM, Gifford AL, Coons SJ. Barriers to use of electronic adherence monitoring in an HIV clinic. Ann Pharmacother. 2001;35(9):1010–5.PubMedCrossRef
6.
Bangsberg DR, Hecht FM, Charlebois ED, Zolopa AR, Holodniy M, Sheiner L, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14(4):357–66.PubMedCrossRef
7.
Kalichman SC, Amaral CM, Cherry C, Flanagan J, Pope H, Eaton L, et al. Monitoring medication adherence by unannounced pill counts conducted by telephone: reliability and criterion-related validity. HIV Clin Trials. 2008;9(5):298–308.PubMedCentralPubMedCrossRef
8.
Bova CA, Fennie KP, Knafl GJ, Dieckhaus KD, Watrous E, Williams AB. Use of electronic monitoring devices to measure antiretroviral adherence: practical considerations. AIDS Behav. 2005;9(1):103–10.PubMedCrossRef
9.
Chesney MA. The elusive gold standard: future perspectives for HIV adherence assessment and intervention. JAIDS. 2006;43:S149–55.PubMed
10.
Krousel-Wood M, Islam T, Webber LS, Re RN, Morisky DE, Muntner P. New medication adherence scale versus pharmacy fill rates in seniors with hypertension. Am J Manag Care. 2009;15(1):59–66.PubMedCentralPubMed
11.
Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348–54.CrossRef
12.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74.PubMedCrossRef
13.
Morisky DE, Levine DM, Green LW, Shapiro S, Russell RP, Smith CR. Five-year blood pressure control and mortality following health education for hypertensive patients. Am J Public Health. 1983;73(2):153–62.PubMedCentralPubMedCrossRef
14.
Simoni JM, Kurth AE, Pearson CR, Pantalone DW, Merrill JO, Frick PA. Self-report measures of antiretroviral therapy adherence: a review with recommendations for HIV research and clinical management. AIDS Behav. 2006;10(3):227–45.PubMedCentralPubMedCrossRef
15.
Wilson IB, Carter AE, Berg KM. Improving the self-report of HIV antiretroviral medication adherence: is the glass half full or half empty? Curr HIV/AIDS Rep. 2009;6(4):177–86.PubMedCentralPubMedCrossRef
16.
Lu M, Safren SA, Skolnik PR, Rogers WH, Coady W, Hardy H, et al. Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behav. 2008;12(1):86–94.PubMedCrossRef
17.
18.
Feldman BJ, Fredericksen RJ, Crane PK, Safren SA, Mugavero MJ, Willig JH, et al. Evaluation of the single-item self-rating adherence scale for use in routine clinical care of people living with HIV. AIDS Behav. 2012;17(1):307–18.CrossRef
19.
Wilson IB, Tchetgen E, Spiegelman D. Patterns of adherence with antiretroviral medications: an examination of between-medication differences. J Acquir Immune Defic Syndr. 2001;28(3):259–63.PubMedCrossRef
20.
McNabb JJ, Nicolau DP, Stoner JA, Ross J. Patterns of adherence to antiretroviral medications: the value of electronic monitoring. AIDS. 2003;17(12):1763–7.PubMedCrossRef
21.
Gardner EM, Burman WJ, Maravi ME, Davidson AJ. Selective drug taking during combination antiretroviral therapy in an unselected clinic population. J Acquir Immune Defic Syndr Human Retrovirol. 2005;40(3):294–300.CrossRef
22.
Gardner EM, Sharma S, Peng G, Hullsiek KH, Burman WJ, MacArthur RD, et al. Differential adherence to combination antiretroviral therapy is associated with virological failure with resistance. AIDS. 2008;22(1):75–82.PubMedCentralPubMedCrossRef
23.
Deschamps AE. de GS, Vandamme AM, Bobbaers H, Peetermans WE, van WE. Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards. AIDS Patient Care STDS. 2008;22(9):735–43.PubMedCrossRef
24.
Tourangeau R. Cognitive science and survey methods. In: Jabine T, editor. Cognitive aspects of survey methodology: Building a bridge between disciplines. Washington, DC: National Academy Press; 1984. p. 73–100.
25.
Tourangeau R, Rips LJ, Rasinski K. The psychology of survey response. New York: Cambridge University Press; 2000.CrossRef
26.
Gaito J. Measurement scales and statistics: resurgence of an old misconception. Psychol Bull. 1982;87:564–7.
27.
Townsend JT, Hu GG, Evans RJ. Modeling feature perception in brief displays with evidence for positive interdependencies. Percept Psychophys. 1984;36(1):35–49.
28.
Ohl ME, Perencevich E, McInnes DK, Kim N, Rimland D, Akgun K, et al. Antiretroviral adherence among rural compared to urban veterans with HIV infection in the United States. AIDS Behav. 2012;17(1):174–80.CrossRef
29.
Beer L, Heffelfinger J, Frazier E, Mattson C, Roter B, Barash E, et al. Use of and adherence to antiretroviral therapy in a Large U.S. Sample of HIV-infected adults in care, 2007–2008. Open AIDS J. 2012;6:213–23.PubMedCentralPubMedCrossRef
30.
Bauermeister JA, Giguere R, Carballo-Dieguez A, Ventuneac A, Eisenberg A. Perceived risks and protective strategies employed by young men who have sex with men (YMSM) when seeking online sexual partners. J Health Commun. 2010;15(6):679–90.PubMedCentralPubMedCrossRef
31.
Harkness JA, Van de Vijver FJR, Mohler PP. fur Umfragen Z. Cross-cultural survey methods. New York: Wiley; 2003.
32.
Marin G, Marin BVO. Research with hispanic populations. Newbury Park: Sage Publications, Inc.; 1991.
Metadata
Title
Cognitive and Field Testing of a New Set of Medication Adherence Self-Report Items for HIV Care
Authors
Ira B. Wilson
Floyd J. Fowler Jr.
Carol A. Cosenza
Joanne Michaud
Judy Bentkover
Aadia Rana
Laura Kogelman
William H. Rogers
Publication date
01-12-2014
Publisher
Springer US
Published in
AIDS and Behavior / Issue 12/2014
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-013-0610-1

Other articles of this Issue 12/2014

AIDS and Behavior 12/2014 Go to the issue

Original Paper

Spatial Recruitment Bias in Respondent-Driven Sampling: Implications for HIV Prevalence Estimation in Urban Heterosexuals

Original Paper

Anticipated and Actual Reactions to Receiving HIV Positive Results Through Self-Testing Among Gay and Bisexual Men

Original Paper

Accuracy of Un-supervised Versus Provider-Supervised Self-administered HIV Testing in Uganda: A Randomized Implementation Trial

Original Paper

Prevalence and Predictors of Concurrent Sexual Partnerships in a Predominantly African American Population in Jackson, Mississippi

Original Paper

Partner Age Differences and Concurrency in South Africa: Implications for HIV-Infection Risk Among Young Women

Original Paper

Feasibility and Acceptability of Cell Phone Diaries to Measure HIV Risk Behavior Among Female Sex Workers

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits